As the activation of Akt and ERK1/2 induces cell proliferation and inhibits apoptosis in various cancers [34,35], the PI3K/Akt and ERK1/2 pathways may be important targets in cancer therapies involving natural bioactive compounds [6,23,28,29,36-38]. The gene discussed is MAPK3; the disease is cancer.